RHEUMATOID ARTHRITIS

1-2% of the world's population has rheumatoid arthritis (RA), a chronic inflammation in the joints. Since it causes inflammation and progressive joint destruction, it is also known as one of the leading causes of disability worldwide. It is caused by an abnormal cell signaling pathway caused by environmental, genetic, and autoimmune factors.

Joint inflammation and pain are common, and range in intensity from quite mild to completely debilitating. In addition, many patients experience flu-like symptoms such as tiredness, loss of appetite, cold extremities, fever, and general weakness.

Pain in multiple joints, stiffness in multiple joints, particularly after sitting or resting for long periods of time, swelling, Systemic symptoms when the disease is active:

Fatigue, weight loss, and low temperature.

Mesenchymal stem cells can enter inflamed and damaged tissues. In this way, stem cells focus on repairing damaged tissues and organs. They can be distinguished from chondrocytes, osteoblasts, and cartilage myocytes. Finally, mesenchymal stem cells constantly work to help slow down the inflammation of arthritis.

Stem cell therapy for patients with rheumatoid arthritis (RA) helps regenerate damaged joint tissue, reduce inflammation, and slow disease progression.